Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: A nonâinferiority randomized trial
Sign Up to like & getrecommendations! Published in 2022 at "Diabetic Medicine"
DOI: 10.1111/dme.15002
Abstract: To compare the efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus (T2D) undergoing coronary artery bypass graft (CABG) surgery. read more here.
Keywords: glargine u300; degludec u100; safety degludec; versus glargine ... See more keywords